Can minority shareholders in an Iranian company challenge a related-party transaction approved by the board?

Yes, potentially. Board approval does not automatically sanitize a conflicted sale. Assuming this is a private joint stock company under Iranian law, a director or managing director who is directly or indirectly interested in a company transaction cannot proceed simply because the board signed off on it. The transaction must follow the conflict procedure, the inspector must be informed, the matter must be reported to the next ordinary general meeting, and the interested director should not vote on it.

That means a sale to a director’s relative can be attacked if the relative was effectively an indirect vehicle for the insider, if the conflict was not properly disclosed, if the conflicted person participated in the vote, or if the asset was sold at a clear undervalue. Iranian company law also states that if loss is caused to the company through such a transaction, the responsible directors and managing director may be jointly liable to indemnify the company.

So the real question is not whether the board approved it, but whether the approval was legally clean and commercially fair. If the board approval was defective and the ordinary general meeting did not validly confirm the transaction, the transaction may be rescindable through court proceedings. Separately, where legal requirements were not followed in the conduct of company affairs or in passing resolutions, an interested person may seek nullity of the company’s operations or resolutions.

Your 15% stake is not meaningless, but it does affect the procedural route. Under the Commercial Code, shareholders holding at least one-fifth, 20%, can require that a general meeting be called, and holders of at least one-fifth can also bring the specific indemnity action for losses caused by directors’ infringement or fault. At 15%, you may be below those two statutory thresholds if acting alone, but you may still have leverage through a nullity challenge, through the company inspector, and by acting together with other shareholders. The law also says company documents or shareholder resolutions cannot block shareholders from suing directors.

The case usually turns on documents, not suspicion. The strongest evidence is normally the board minutes, notice and agenda, voting record, inspector’s report, the sale agreement, valuation material showing fair market value, proof of the relationship between the buyer and the director, payment trail, bank records, internal correspondence, and the company’s balance sheet and profit and loss documents. Iranian law gives shareholders pre-meeting access to key financial and reporting documents, and gives inspectors broad power to investigate the company’s records and demand information.

If the transaction was concealed, timing becomes even more important. The rescission route for conflicted transactions can run within three years from the date of the transaction, and if it was done secretly, within three years from discovery. That is why these cases should usually be assessed quickly, before records are reshaped and before procedural windows narrow.

There may also be more than civil exposure here. The Commercial Code separately provides criminal consequences where directors use company property or powers against the company’s interests for their own benefit, or for the benefit of another concern in which they are directly or indirectly interested, and it also penalizes obstructing inspectors or withholding records from them. If the undervalued sale was part of a deliberate insider extraction scheme, that can materially strengthen the pressure on the other side.

In practical terms, this is often a winnable type of minority-shareholder dispute when three points can be shown clearly: hidden interest, broken procedure, and undervalue. If those three align, the board resolution stops looking like business judgment and starts looking like an abusive related-party transfer that can be challenged and monetized.

Yes, potentially. Board approval does not automatically sanitize a conflicted sale. Assuming this is a private joint stock company under Iranian law, a director or managing director who is directly or indirectly interested in a company transaction cannot proceed simply because the board signed off on it. The transaction must follow the conflict procedure, the inspector must be informed, the matter must be reported to the next ordinary general meeting, and the interested director should not vote on it.

That means a sale to a director’s relative can be attacked if the relative was effectively an indirect vehicle for the insider, if the conflict was not properly disclosed, if the conflicted person participated in the vote, or if the asset was sold at a clear undervalue. Iranian company law also states that if loss is caused to the company through such a transaction, the responsible directors and managing director may be jointly liable to indemnify the company.

So the real question is not whether the board approved it, but whether the approval was legally clean and commercially fair. If the board approval was defective and the ordinary general meeting did not validly confirm the transaction, the transaction may be rescindable through court proceedings. Separately, where legal requirements were not followed in the conduct of company affairs or in passing resolutions, an interested person may seek nullity of the company’s operations or resolutions.

Your 15% stake is not meaningless, but it does affect the procedural route. Under the Commercial Code, shareholders holding at least one-fifth, 20%, can require that a general meeting be called, and holders of at least one-fifth can also bring the specific indemnity action for losses caused by directors’ infringement or fault. At 15%, you may be below those two statutory thresholds if acting alone, but you may still have leverage through a nullity challenge, through the company inspector, and by acting together with other shareholders. The law also says company documents or shareholder resolutions cannot block shareholders from suing directors.

The case usually turns on documents, not suspicion. The strongest evidence is normally the board minutes, notice and agenda, voting record, inspector’s report, the sale agreement, valuation material showing fair market value, proof of the relationship between the buyer and the director, payment trail, bank records, internal correspondence, and the company’s balance sheet and profit and loss documents. Iranian law gives shareholders pre-meeting access to key financial and reporting documents, and gives inspectors broad power to investigate the company’s records and demand information.

If the transaction was concealed, timing becomes even more important. The rescission route for conflicted transactions can run within three years from the date of the transaction, and if it was done secretly, within three years from discovery. That is why these cases should usually be assessed quickly, before records are reshaped and before procedural windows narrow.

There may also be more than civil exposure here. The Commercial Code separately provides criminal consequences where directors use company property or powers against the company’s interests for their own benefit, or for the benefit of another concern in which they are directly or indirectly interested, and it also penalizes obstructing inspectors or withholding records from them. If the undervalued sale was part of a deliberate insider extraction scheme, that can materially strengthen the pressure on the other side.

In practical terms, this is often a winnable type of minority-shareholder dispute when three points can be shown clearly: hidden interest, broken procedure, and undervalue. If those three align, the board resolution stops looking like business judgment and starts looking like an abusive related-party transfer that can be challenged and monetized.